← The Wire
CUENasdaq
Cue Biopharma, Inc.
Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
red 8-K · 90d
$103M
Market cap
$30.43
Last close
+19.9%
1D
-1.0%
5D
164K
Volume
Price · last 39 sessions+1.9%
May 4L $20.03 · H $35.73Jun 29
176
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
S-1/AS-1/A - AMENDMENT NO. 1Jul 13, 2018S-1/AAMENDMENT NO. 5 TO FORM S-1Dec 13, 2017S-1/AAMENDMENT NO. 4 TO FORM S-1Dec 11, 2017S-1/AAMENDMENT NO. 3 TO FORM S-1Dec 5, 2017S-1/AAMENDMENT NO. 2 TO FORM S-1Nov 17, 2017S-1/AAMENDMENT NO. 1 TO FORM S-1Nov 2, 2017
Insider Activity
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance